# FDA recall D-0649-2017

> **Dr. Reddy's Laboratories, Inc.** · Class III · drug recall initiated 2017-03-06.

## Product

RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally 500-900 India, NDC 55111-352-60

## Reason for recall

Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.

## Distribution

U.S. nationwide

## Key facts

- **Recall number:** D-0649-2017
- **Recalling firm:** Dr. Reddy's Laboratories, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-03-06
- **Report date:** 2017-04-12
- **Termination date:** 2017-12-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0649-2017

## Citation

> AI Analytics. FDA recall D-0649-2017. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0649-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*